The exploration of the concentration of isoxanthopterine in urine with type 2 diabetes mellitus and metabolic syndrome.

The exploration of the implication of measuring the concentration of isoxanthopterine in urine with type 2 diabetes mellitus and metabolic syndrome. - The explaration of the implication of measuring the concentration of isoxanthopterine in urine with type 2 diabetes mellitus and metabolic syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050752

Enrollment

Registered

2023-04-27

Start date

2023-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 diabetes mellitus and metabolic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Obese, type 2 diabetes and metabolic syndrome patients who are currently attending the University of the Ryukyus Hospital and affiliated hospital and healthy volunteer.

Exclusion criteria

Exclusion criteria: Patients who are assessed by the attending physician to be inappropriate for the study.

Design outcomes

Primary

Measure	Time frame
urine isoxanthopterin consentration	—

Secondary

Measure	Time frame
alanine aminotransferase:ALT, insulin resistance	—

Countries

Japan

Contacts

Public ContactRei Chinen

Graduate School of Medicine, University of the Ryukyus. Division of Endocrinology, Diabetes and Metabolism,Hematology, Rheumatology.

reda461@ryudai2nai.com098-895-1146

Outcome results